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on the Visual Function Questionnaire – Utility Index and subsequent mapping to 
BCVA. Both costs (2012 Canadian dollars) and outcomes were discounted (5%). A 
Canadian panel of clinical experts in the treatment of CRVO validated the model 
structure and resource utilization. One-way and probabilistic sensitivity analyses 
(PSAs), were performed to test the robustness of the model to variations in key 
inputs. RESULTS: The resulting incremental cost-utility analysis (ICUR) was 
$21,568 and $14,103 from the public payer and societal perspective, respectively, 
for OZURDEXTM versus observation. Results of the one-way and multivariate 
analysis suggest that the results were robust. Throughout the 1,000 iterations  
of the PSA the ICUR consistently fell below a willingness-to-pay threshold of 
$50,000/QALY gained. Although robust, the model was most sensitive to age  
of entry and the utilities used for both the best-seeing eye and worst-seeing  
eye. CONCLUSIONS: Based on a willingness-to-pay threshold of $50,000/QALY 
gained, OZURDEX™ is a cost-effective treatment for CRVO compared with 
observation.  
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VALIDATION AND COMPARISON OF THE SF-6D AND EQ-5D IN CHINESE 
PATIENTS WITH MODERATE TO SEVERE PSORIASIS  
Zhao M1, Wu J1, Zheng M2, Zheng ZZ3, Yue N4 
1Tianjin University, Tianjin, China, 2Second Affiliated Hospital Zhejiang University College of 
Medicine, Hangzhou, China, 3Huashan Hospital, Fudan University, Shanghai, China, 4Johnson & 
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OBJECTIVES: To validate and compare the psychometric properties of two 
generic preference-based HRQoL instruments, EuroQol (EQ-5D) and Short-Form 
6D (SF-6D) among psoriasis patients in China. METHODS: Validity of the EQ-5D 
and SF-6D was examined with the patients in conjunction with Dermatology Life 
Quality Index (DLQI). Responsiveness was tested using the effect size (ES), 
relative efficiency (RE) and receiver operating characteristic (ROC) curves. 
Agreement between EQ-5D and SF-6D was tested using intra-class correlation 
coefficient (ICC) and Bland-Altman plot. RESULTS: A total of 150 moderate to 
severe patients were included with 50% female, mean age of 43.87 and mean 
disease duration of 5.19 years. The mean utility scores (SD) were 0.64 (0.32) for 
EQ-5D and 0.72(0.12) for SF-6D. There were no serious floor effects for EQ-5D and 
SF-6D but large ceiling effects for EQ-5D existed. Validity was demonstrated by 
the moderate to strong correlation coefficients (range: 0.50-0.71, P<0.001) for six 
of the ten hypotheses in both instruments. Both of EQ-5D and SF-6D showed a 
well discriminative capacity similarly (ES=0.98-1.27, ES=0.99-1.26) between 
groups with different psoriasis specific health status. RE showed that SF-6D 
(6.00-39.00%) was more efficient than EQ-5D in three domains of DLQI  
(recreation, relationships and treatment). Conversely, SF-6D (−1.00 - −13.00%) was 
less efficient than EQ-5D in three domains of DLQI (symptoms and feelings, daily 
activities and work and studies). The areas under ROC of them all exceeded  
0.5 (0.71- 0.84, P<0.001). Poor agreement between them was observed with  
ICC (0.38, P<0.001) and Bland-Altman plot analysis. CONCLUSIONS: This  
study provides evidence that EQ-5D and SF-6D are valid and sensitive 
preference-based HRQoL instruments in Chinese patients with moderate to 
severe psoriasis. SF-6D may be a more effective tool with lower ceiling effect. 
Further study is needed to compare other properties, such as reliability and 
longitudinal response.  
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OBJECTIVES: To assess health utilities and examine factors affecting health utilities 
among patients with moderate to severe psoriasis in China. METHODS: Data were 
obtained from a cross-sectional HRQoL survey of psoriasis patients in 29 tertiary 
hospitals of 7 cities in China from June to July, 2012. Eligible patients were assessed 
with moderate to severe psoriasis by physicians and treated with prescriptions 
during the visit/hospitalization. Degree of moderate and severe was estimated by 
physicians based on definition of BSA score 3-10% and >10%. Participants 
completed HRQoL measures of EuroQol 5 domains (EQ-5D), Short Form 6 domains 
(SF-6D) and Dermatology Life Quality Index (DLQI). Socio-demographic and 
treatment satisfaction information were also collected from the participants. Mean 
scores were compared and stepwise multivariate linear regression was conducted 
to assess factors associated with health utilities. RESULTS: A total of 150 patients 
were included with 50% female, mean age of 43.87 years and mean disease duration 
of 5.19 years. About 22.67% patients reported having at least one comorbidity with 
anxiety/depression (14.00%) and related infection (10.00%) listed on the top. 36.67% 
patients expressed dissatisfaction with their current treatment. Mean EQ-5D,  
EQ-VAS, SF-6D and DLQI scores were 0.64, 63.23, 0.72 and 11.09, respectively, with 
significant difference between the severe and moderate group in all measures(0.50 
vs. 0.77, 58.12 vs. 67.48, 0.67 vs.0.75, 14.43 vs. 8.33, all p<0.001). Regression analysis 
indicated that health severity indicated by DLQI score was significantly associated 
with value scores of EQ-5D, EQ-VAS, SF-6D. Sleeplessness and living in Tier 1st city 
decreased EQ-5D and SF-6D scores and treatment dissatisfaction had the negative 
impact on EQ-VAS and SF-6D scores with statistic significant. CONCLUSIONS: 
Compared with moderate patients, patients with severe psoriasis have poorer 
health utilities. Increasing the patients’ satisfaction with their treatment and 
controlling insomnia may raise their health utilities effectively.  
PSS15  
UNDERSTANDING THE PSORIASIS PATIENT PERSPECTIVE: USING A 
COMBINATION OF QUALITATIVE AND QUANTITATIVE ANALYSES TO EXPLORE 
AND DESCRIBE SYMPTOMS, IMPACTS, AND TREATMENT-RELATED 
EXPERIENCES ACROSS THE COURSE OF DISEASE  
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OBJECTIVES: Psoriasis (PsO) is a systemic, inflammatory disease manifesting in 
the skin and associated with psoriatic arthritis. The objective of this study was to 
describe and quantify patients’ disease experiences, including symptoms and 
impact on daily lives and function. METHODS: This observational study was 
conducted in patients with moderate-to-severe PsO across 8 US sites. Qualitative 
data were obtained through semi-structured face-to-face interviews, including 
open-ended questions and patients’ ranking of bothersome symptoms. 
Quantitative data were captured using a case report form addressing 
demographic and clinical characteristics and standard measures of disease 
severity. Each interview was transcribed and thematically coded; all mentions of 
symptoms and areas of life-impact were quantified. Qualitative (ATLAS.ti) and 
quantitative (SAS) software analysis tools were used. RESULTS: A total of 101 
patients participated. Mean age was 49 years (SD = 14), mean duration of disease 
was 19 years, and 54% were male. Patients averaged 15% of body surface area 
involved with PsO. Mean Psoriasis Area and Severity Index score was 8.7 (SD = 
8.0) and 46% of patients were receiving biologic therapy. The most frequent 
patient-reported symptoms were flaking/scaling (non-scalp areas) (90%), 
itching/scratching (88%), rash (75%), flaking/scaling (scalp area) (63%), skin pain 
(63%), skin bleeding (59%), and redness (58%). Most bothersome symptoms were 
itching/scratching, flaking/scaling (non-scalp areas), and skin pain. Nearly all 
patients reported an emotional (98%) and social (95%) life-impact. Other impacts 
included family (74% of patients), professional (69%), physical (52%), educational 
(23%), and sexual (21%). Positive and negative treatment-related experiences 
were reported. CONCLUSIONS: Results provide a detailed description of PsO 
symptoms and identify important targets for treatment based on the patient 
perspective. PsO has a significant multidimensional impact on patients’ lives. 
Recording patient interviews and coding the themes, symptoms, and impacts of 
PsO provide rich material for analysis of patients’ health-related quality of life.  
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PATIENT REPORTED OUTCOMES IN GLAUCOMA A SYSTEMATIC REVIEW  
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Novel Health Strategies, Bethesda, MD, USA  
OBJECTIVES: Patient reported outcomes (PRO) are becoming useful tools for 
collecting and generating evidence for new medical products to show 
improvements in health-related quality of life (HRQoL). Glaucoma is a chronic 
disease with high importance for patient HRQoL. The objective of this study was 
to review, analyze, and understand trends in the PRO instruments used in 
patients with Glaucoma. METHODS: A systematic literature search for Glaucoma 
trials with PROs endpoints was undertaken for the databases Pubmed, Embase, 
Biosis, Google Scholar and Cochrane. Data was collected for the study size, 
interventions, year, PRO instrument and results for PROs. Analysis for conducted 
to identify trends in commonly used PRO instruments and categorize results as 
positive, neutral or negative. RESULTS: Thirty-one studies with a total of 9819 
patients were identified. In these studies there were eleven different PROs 
instruments were identified that were Glaucoma health perception index, 
Glaucoma quality of life questionnaire (Glau-QoL), Glaucoma utility index, 
Impact of vision impairment, Low vision quality of life questionnaire, National 
eye institute visual function index-19 items, National eye institute visual 
function index-51 items, Nursing home vision quality of life questionnaire, 
Quality of life and visual function questionnaire, Vision core module 1, and 
Vision quality of life index. The most commonly used instruments were Impact 
of vision impairment (used in 7 studies) and Low vision quality of life 
questionnaire (used in 4 studies). CONCLUSIONS: Patients with glaucoma have 
significant impairment in their QoL, hence collection of such data is important 
for new medical products. PRO instruments such as Impact of vision impairment 
and Low vision quality of life questionnaire have been commonly used to 
generate evidence to show which therapies improve patient QoL.  
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OBJECTIVES: To develop a conceptual framework of functional reading 
independence to support development of a patient-reported outcome (PRO) 
measure for patients with geographic atrophy (GA) from age-related macular 
degeneration. METHODS: The conceptual framework was developed based  
on a literature review, expert opinion and patient input. Patient input was 
gathered in a qualitative concept elicitation study with 23 GA patients, where 
functional reading independence emerged as the most relevant concept. A draft 
conceptual framework and PRO questionnaire (interviewer-administered) were 
developed. Cognitive interviews were then conducted with 17 additional  
GA patients to assess understanding, completeness and relevance of the concept 
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and items. Feedback on the questionnaire was also obtained from the  
patient interviewers, clinical experts and a translation expert. The conceptual 
framework and questionnaire were subsequently revised. RESULTS:  
The conceptual framework represents functional reading independence  
as a unidimensional concept. Eleven functional reading activities have a  
direct effect on functional reading independence: 1) reading written print; 2) 
reading to pay bills or write a check; 3) reading in order to take medicine; 4) 
reading instructions; 5) reading labels; 6) reading to play games; 7) reading to 
make or receive a telephone call; 8) reading words or numbers on the screen 
while watching television; 9) reading when using a computer; 10) reading street 
signs; and 11) reading signs for directions. The process of performing each 
functional reading activity may be completely independent, or may involve the 
use of vision aids, behavior changes to accommodate vision problems, and/or 
receiving help from another person. CONCLUSIONS: To our knowledge, this is 
the first conceptual framework specifically representing functional reading 
independence from the perspective of patients with GA. The conceptual 
framework may evolve once empirical evidence is available. The questionnaire 
based on the conceptual framework is currently being tested in a Phase II clinical 
trial.  
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OBJECTIVES: Wet Age-related Macular Degeneration (wAMD) is one of the major 
causes of visual impairment in Japan. However the patient burden from wAMD 
has not been widely reported. The objective of this study was to characterize 
how Japanese wAMD patients are affected by the disease. METHODS: This is a 
multi-site observational study across Japan on wAMD patients who have 
received medical treatment during the past 12 months. Collected patient-
reported outcome measures included Quality of Life using the National Eye 
Institute Visual Functioning Questionnaire-25 (NEI-VFQ-25) and depression scale 
by the Geriatric Depression Scale-Short Version-Japanese (GDS-S-J). Patients also 
reported on treatment satisfaction, caregiver assistance, and wAMD-associated 
comorbidities. RESULTS: Interim data for 211 patients are reported here; 97.2% of 
patients were 60 years of age and over. The mean score of NEI-VFQ-25 was 
68.19±17.84 and General Vision (45.78±18.07) was the lowest among 12 sub-
domains; 11.4% of patients had a score of 6 or above in GDS-S-J, indicating mild 
depression. A total of 38.4% and 45.5% of patients were dissatisfied with their 
treatment in terms on vision improvement and the time it takes for the 
treatment to work, respectively. A total of 10.4% of patients needed assistance 
with their daily tasks, but of those, only 4.7% had a caregiver to help them day-
to-day. 1.9% used paid services at home with the average of 1.3±0.47 hours per 
week; half of these patients used yearlong service and the rest used 6 months 
only; 5.9% of patients visited other doctors because of a fall which was related to 
their vision impairment. CONCLUSIONS: Our analyses showed that 38-45% of 
patients were dissatisfied with their current treatment. Very few patients who 
required assistance were able to have a caregiver to help them day-to-day. Paid 
services were also barely utilized.  
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OBJECTIVES: Manufacturers underestimate the time till reimbursement in the 
US for dermatology products and procedures. The purpose of this study was to 
examine the factors influencing time to reimbursement for different products 
and procedures and to identify strategies for ensuring optimal reimbursement 
status and CPT code valuation for such products, including consideration of the 
appropriate distribution channel. METHODS: The study involved 25 interviews 
with commercial medical and pharmacy directors, specialty pharmacy 
distributors, dermatologists and dermatology office managers. Interviews 
focussed on the perceptions and experiences of the interviewees in the 
prescribing of, and reimbursement for, new dermatology products and 
procedures. An analysis of historical coding evaluations for dermatological 
procedures was conducted and the challenges in building a valuation that is 
commercially viable were identified. RESULTS: Interviewees had multiple 
experiences of lacking the appropriate codes to secure reimbursement for the 
use of new dermatology products and procedures. These experiences have 
resulted in a situation where initial uptake of new products is out of line with 
the expectations of manufacturers. The process for informing the valuation of 
codes was considered to be highly politicised, with a need for extensive 
investment in supporting the case for the relative value units of a procedure. 
“Buy and bill” distribution routes were considered to be unsatisfactory from the 
point of view of dermatologist offices based. CONCLUSIONS: Manufacturers of 
new dermatology products that require the use of a procedure need to carefully 
consider their strategy for ensuring a reimbursement status and distribution 
route that enables dermatology offices to be reassured in using their product. A 
lack of planning may result in a total lack of uptake even for products that are of 
recognised clinical benefit.  
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OBJECTIVES: Ustekinumab is dosed at 45mg or 90mg (patient weight-dependent) 
in moderate-to-severe plaque psoriasis. The study objective was to assess 
observed increases (step-up from 45mg to 90mg) or decreases (step-down from 
90mg to 45mg) in ustekinumab dosing. METHODS: Truven Health MarketScan® 
Commercial and Medicare Supplemental databases were utilized to evaluate 
patients with: 1 ustekinumab index medical/pharmacy claim (09/25/2009-
10/31/2010); age ≥18 years at index; ≥ 6 months pre-index continuous enrollment; 
and ≥1 psoriasis diagnosis code (696.1) on or pre-index. Step-up and step-down 
dosing events and distribution of subsequent doses at each fill (doses 2-4) were 
assessed based on index dose received. Time to step-up or step-down was 
reported in days. RESULTS: Of 1,000 psoriasis patients receiving ustekinumab, 
step-up and step-down dosing events at anytime were evident in 9.9% (n=99) and 
6.8% (n=68), respectively. Median (mean±SD) time to step-up from index dose 
was 119 (113±76) days. Median (mean±SD) time to step-down from index dose 
was 49 (69±52) days. Of patients with step-up events, 37.4% returned to their 
original 45mg dose after step-up (mean=66 days). Of patients with step-down 
events, 39.7% returned to their original 90mg dose after step-down (mean=158 
days). Proportion of 45mg use by index 90mg patients spanned 6.1%-7.8% across 
doses. Proportion of 90mg use by index 45mg patients spanned 1.4%-16.8% 
across doses. CONCLUSIONS: In this observational study, <10% of psoriasis 
patients receiving ustekinumab had evidence of step-up/step-down dosing 
events at anytime. Over 1/3 of patients with either event returned to initial dose. 
Mean time to step-up was longer than mean time to step-down from initial dose 
by approximately 6 weeks. Step-up patients returned to lower initial dosing in a 
shorter period of time compared to step-down patients returning to higher initial 
dosing. Step-up/step-down dosing should be explored further in the context of 
weight, effectiveness, and safety.  
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GEOGRAPHICAL DIFFERENCES IN THE UTILIZATION OF DENTAL SERVICES IN 
HUNGARY  
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OBJECTIVES: The aim of this study was to assess the annual health insurance 
reimbursement of dental health service in counties and regions of Hungary. 
METHODS: The assessment base of the study was the annual reports of National 
Health Insurance Fund Administration (OEP). Only the data collected from the 
services in contractual relationship with the OEP and delivered between 2008 
and 2011 were evaluated. Our study covers primary, outpatient and hospital 
dental care.We analyzed the following indicators: number of cases(patients) per 
100 inhabitants, number of intervention (procedures) per 100 inhabitant, 
intervention per case, and reimbursement per intervention. RESULTS: Dental 
care was supplied by 3366 general and specialist dental care services at the end 
of 2011. The average number of cases per 100 inhabitants was 71 and varied 
between 55-95 in different counties. The average number of interventions per 
100 inhabitants was 199 and varied between 149-268 in different counties. The 
average number of interventions per case was 2.8 (2.56-3.13). The average 
reimbursement per intervention showed also significant differences among the 
counties (1018-1217) with an average of 1122 Hungarian Forint per case. Due to 
the progressive dental care system in those counties were university dental 
school can be found, the utilization of dental services is higher than in counties 
without dental school. CONCLUSIONS: Within the period under investigation, 
the health insurance reimbursement of dental care showed significant 
differences among counties and regions of Hungary. The presence of dental 
school is an important predictive factor for higher than national average 
utilization of dental services.  
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OBJECTIVES: Actinic keratoses are characterized by dysplastic epidermal lesions 
that occur in pale-skinned individuals chronically exposed to intense sunlight. It 
is one of the most commonly treated skin conditions but its prevalence in the 
Brazilian population is still unknown. The objective of this research is to describe 
the profile of the patients diagnosed with AK in São Paulo city. METHODS: A two 
months health survey was performed in the city of São Paulo in which 10 
dermatologists registered the profile of the patients diagnosed with actinic 
keratosis. RESULTS: The dermatologists saw 4961 patients in two months, 5,4% 
(269 patients), were diagnosed with AK (58% women). The mean age of the 
patients was 65 years old. 42% informed a family history of AK and 21% history 
of nonmelanoma skin cancer. Among the patients 80% of the participants 
belonged to the two initial categories of the Fitzpatrick Scale. 39% of the lesions 
were hyperkeratotic and the most common localizations of the lesions were face 
(35%) and the upper extremity (26%). Seventy-one percent of the patients were 
treated with surgical destruction of the lesions (chemical cautery, cryotherapy, 
electrocautery) and just 29% were prescribed to administer topical therapy (5-
fluourouracil, imiquimod, retinoic acid). CONCLUSIONS: The prevalence of 
actinic keratosis in this sample is 5,42%. The most affected sites were face and 
